Trial NCT00298272

View at ClinicalTrials.gov 
Org. Study IDs: 102-RA-201

Last trial update was posted on 2015-09-28

MeSH Interventions

Adalimumab Etanercept Methotrexate Methylprednisolone Rituximab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

Sponsor decided to end long term extension phase for business reasons unrelated to safety.

Limitations And Caveats

Sponsor made a business decision to terminate study on 28 July 2011, after completion of the primary endpoint and during the long-term extension phase. One participant was still in extended safety follow-up and was referred for appropriate care.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID